Novel tissue factor/factor VIIa inhibitor reduces ischemia in patients with nSTE-ACS: Results of the dose-ranging and heparin de-escalation phases of the ANTHEM-TIMI 32 Trial

Author Department

Medicine

Document Type

Presentations, Research

Publication Date

10-1-2006

Share

COinS